ARZNEIMITTELPROTEINKONJUGATE

European patent · EP2911700 · In force

Register entry

Publication number
EP2911700
Application number
EP13786530
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 11, 2013
Published
Sep 2, 2015
Granted
Feb 8, 2017
Protection ends at the latest
Oct 10, 2033
Next annual fee due
Oct 31, 2026
IPC classes
A61K 47/68 (2017.01)
Priority
US 201261717710 P 24.10.2012
US 201261717743 P 24.10.2012
US 201361811285 P 12.04.2013
WO PCT/GB2013/051593 19.06.2013
PCT application
PCT/GB2013/052661 11.10.2013
PCT publication
WO2014/064423 01.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Mar 10, 2017

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 10.03.2017

  6. Feb 8, 2017

    Granted

    Published in Swissreg on 08.02.2017

Parties

Holder

Polytherics Limited

Babraham Research Campus, Babraham Cambridge CB22 3AT, GB

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

BURT, John

Cambridge CB22 3AT, GB

GODWIN, Antony

Cambridge CB22 3AT, GB

FRIGERIO, Mark

Cambridge CB22 3AT, GB

BADESCU, George

Cambridge CB22 3AT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.